icon About

ACADEMY'S
TABLE OF CONTENT

TOTAL ACADEMY CHAPTERS: 473

Journal club (includes abcc pathway articles)

  1. Update on Nonpsychotic Unipolar Depression Management
  2. Omega-3 Fatty Acids for Major Depressive Disorder Treatment.
  3. Bipolar Depression Guidelines: CANMAT & ISBD Versus Psychopharmacology Algorithm Project
  4. How does Schizophrenia Symptoms Progress with Age?
  5. Comparing 32 Oral Antipsychotics for Acute Multi-Episode Schizophrenia Treatment.
  6. Lumateperone for Treatment of Schizophrenia.
  7. Non-D2-Receptor-Binding Medication for Schizophrenia.
  8. Is Vortioxetine Effective for Emotional Blunting in MDD?
  9. Adjunctive Metformin for Antipsychotic-Induced Dyslipidemia.
  10. Antipsychotics and Weight Gain.
  11. Benzodiazepines & Risk of Subsequent Dementia.
  12. International Trauma Questionnaire (ITQ) for PTSD & CPTSD Assessment.
  13. Antipsychotics, High Prolactin & Risk of Breast Cancer
  14. Dose-Response Meta-Analysis of Antipsychotics for Acute Schizophrenia
  15. Clinical Interpretation of Urine Drug Tests
  16. Lithium During Pregnancy & Postpartum
  17. Low Testosterone Level in Outpatient Psychiatry Clinic
  18. Anorexia Nervosa: How to Diagnose, Evaluate & Treat
  19. Psilocybin for Treatment Resistant Depression
  20. Cannabis Use in Adolescence & Risk of Schizophrenia
  21. Apathy as Treatment Target for Alzheimer’s Disease
  22. Harmonizing the Neurobiology & Treatment of Obsessive-Compulsive Disorder
  23. Psilocybin for Treatment-Resistant Bipolar 2 Depression
  24. Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse

CLINICAL CASE DISCUSSIONS:

  1. Anxiety Post Chronic Benzodiazepine Discontinuation
  2. Hydroxychloroquine & Psychotropics
  3. Antidepressant of Choice with Treatment Resistant Hypertension?
  4. Antidepressant use in Elderly with Reduced Renal Function
  5. Antidepressants & Anticoagulants
  6. QTc Prolongation & Psychotropics
  7. Hyponatremia Risk with Antidepressants
  8. Clozapine & Norclozapine Level: Clinical Relevance

PSYCHOPHARMACOLOGY WITH RENAL IMPAIRMENT:

ANTIDEPRESSANTS use with RENAL IMPAIRMENT

  1. Renal Impairment Classifications
  2. SSRIs (Selective Serotonin Reuptake Inhibitors)
  3. SNRIs (Serotonin Norepinephrine Reuptake Inhibitors)
  4. NDRI (Norepinephrine Dopamine Reuptake Inhibitors)
  5. NaSSAs (Noradrenergics & Specific Serotonergics)
  6. Serotonin Modulators
  7. NRI (Norepinephrine Reuptake Inhibitors)
  8. TCAs (TriCyclic Antidepressants)
  9. MAOIs (MonoAmine Oxidase Inhibitors)

ANTIPSYCHOTICS use with RENAL IMPAIRMENT

  1. Renal Impairment Classifications
  2. Atypical Antipsychotics
  3. Typical Antipsychotics

MOOD STABILIZERS use with RENAL IMPAIRMENT

  1. Mood Stabilizers

ANTI-ANXIETY MEDICATIONS use with RENAL IMPAIRMENT

  1. Anti-Anxiety Medications

HYPNOTICS use with RENAL IMPAIRMENT

  1. Hypnotics

PSYCHOPHARMACOLOGY WITH HEPATIC IMPAIRMENT:

ANTIDEPRESSANTS use with HEPATIC IMPAIRMENT

  1. SSRIs (Selective Serotonin Reuptake Inhibitors)
  2. SNRIs (Serotonin Norepinephrine Reuptake Inhibitors)
  3. NDRI (Norepinephrine Dopamine Reuptake Inhibitors)
  4. NaSSAs (Noradrenergics & Specific Serotonergics)
  5. Serotonin Modulators
  6. NRI (Norepinephrine Reuptake Inhibitors)
  7. TCAs (TriCyclic Antidepressants)

ANTIPSYCHOTICS use with HEPATIC IMPAIRMENT

  1. Atypical Antipsychotics
  2. Typical Antipsychotics

MOOD STABILIZERS use with HEPATIC IMPAIRMENT

  1. Mood Stabilizers

HYPNOTICS use with HEPATIC IMPAIRMENT

  1. Hypnotics

ANTIDEPRESSANTS use with HEPATITIS C

  1. Antidepressants use with Hepatitis C

PSYCHOPHARMACOLOGY WITH CARDIAC IMPAIRMENT:

ANTIDEPRESSANTS use with QTc PROLONGATION RISK

  1. QTc: How Long is Too Long?
  2. High Risk Antidepressants
  3. Moderate Risk Antidepressants
  4. Low/No Risk Antidepressants

ANTIPSYCHOTICS use with QTc PROLONGATION RISK

  1. QTc: How Long is Too Long?
  2. High Risk Antipsychotics
  3. Moderate Risk Antipsychotics
  4. Low Risk Antipsychotics
  5. Minimal Risk Antipsychotics
  6. Psychosis Management in Hospital with QTc Prolongation Risk

ADHD MEDICATIONS use with QTc PROLONGATION RISK

  1. ADHD Medications

OPIOID DEPENDENCE MEDICATIONS use with QTc PROLONGATION RISK

  1. Opioid Dependence Medications

PARKINSON DISEASE MEDICATIONS use with QTc PROLONGATION RISK

  1. Parkinson Disease Medications

Psychotropics with ATRIAL FIBRILLATIONS

  1. Antidepressants with Atrial Fibrillation
  2. Antipsychotics with Atrial Fibrillation
  3. Mood Stabilizers with Atrial Fibrillation

PSYCHOPHARMACOLOGY WITH OTHER MEDICAL COMORBIDITIES:

Bleeding and Thrombocytopenia

  1. Antidepressants & risk of BLEEDING: Thrombocytopenia Evaluation

Hyponatremia

  1. Symptoms, Workup and Differential Diagnosis
  2. Antidepressants & Risk of Hyponatremia

Increased Prolactin Levels

  1. Clinical Features & Evaluations
  2. Antipsychotics & High Prolactin
  3. Antidepressants & High Prolactin
  4. Management of High Prolactin Level

Seizures

  1. Antidepressants
  2. Typical Antipsychotics
  3. Atypical Antipsychotics

RLS (Restless Leg Syndrome) and PLM (Periodic Limb Movements)

  1. Antidepressants

Tinnitus

  1. Tinnitus & Psychotropics

HIV/AIDS

  1. Antidepressants
  2. Anti-Anxiety Medications
  3. Mood Stabilizers
  4. Antipsychotics
  5. Delirium Treatment

Transplant Patients

  1. SSRIs (Selective Serotonin Reuptake Inhibitors)
  2. SNRIs (Serotonin Norepinephrine Reuptake Inhibitors)
  3. NDRI (Norepinephrine Dopamine Reuptake Inhibitors)
  4. Serotonin Modulators
  5. TCAs (Tricyclic Antidepressants)

Oncology Patients

  1. Antidepressants

Functional Dyspepsia

  1. Antidepressants

Pulmonary Disease

  1. Antidepressants
  2. Benzodiazepines and Non-Benzodiazepines
  3. Antipsychotics

ADVERSE EVENTS: ANTIPSYCHOTICS

Clozapine Adverse Events Management

  1. Hematologic Side Effects Management
  2. Cardiac Side Effects Management
  3. Neurological Side Effects Management
  4. Gastrointestinal Side Effects Management
  5. Hypersalivation with Clozapine
  6. Clozapine Withdrawal: Cholinergic Rebound

Weight Gain & Metabolic Syndrome

  1. Update 2023: Antipsychotics & Weight Gain
  2. Dose-Response Meta-Analysis of Antipsychotics for Acute Schizophrenia
  3. 2014 Study: Almost All Antipsychotics Result In Weight Gain
  4. 2019 Study: Comparing 32 Oral Antipsychotics
  5. Metformin for Antipsychotic induced Weight Gain Management
  6. Samidorphan for Antipsychotic induced Weight Gain Management
  7. Melatonin for Antipsychotics Induced Metabolic Syndrome
  8. New Era of Weight Loss Medications

Akathisia: Treatment Options

  1. Antipsychotics Induced Akathisia: Treatment Options

Tardive Dyskinesias Management

  1. Tardive Dyskinesia: Introduction
  2. Tardive Dyskinesia Management
  3. Comparing VMAT-2 Inhibitors for Tardive Dyskinesia

Gynecomastia

  1. Risperidone and Gynecomastia- Rule out Pseudogynecomastia

Edema

  1. Antipsychotics Induced Edema: Evaluation & Management.

Nocturnal Enuresis

  1. Antipsychotics & Nocturnal Enuresis

Hypersexual and Paraphilic Behaviors

  1. Antipsychotics & Hypersexual or Paraphilic Behaviors

Psychiatric Emergencies

  1. Neuroleptic Malignant Syndrome Vs Serotonin Syndrome (Part 1)
  2. Neuroleptic Malignant Syndrome Vs Serotonin Syndrome Vs Anticholinergic Toxicity Vs Malignant Hyperthermia (Part 2)

ADVERSE EVENTS: ANTIDEPRESSANTS

Bruxism (Jaw Clenching)

Excessive Sweating

Emotional Blunting

Weight Gain

Dry Mouth (Xerostomia)

Seizure Risk

Priapism

Citalopram, Escitalopram, QTc and FDA Warning

Psychiatric Emergencies

ADVERSE EVENTS: MOOD STABILIZERS

Lithium

  1. Lithium & Polyuria/Polydipsia
  2. Lithium & Tremors
  3. Lithium & Hypothyroidism
  4. Lithium and Hypercalcemia & Hyperparathyroidism
  5. Lithium & GI Side Effects
  6. Lithium & Neuropathy

Valproate

  1. Valproate & Thrombocytopenia
  2. Valproate & Hair Loss
  3. Valproate & High Ammonia
  4. Valproate & Tremors

Lamotrigine

  1. Lamotrigine & Rashes: Treatment & Differentiating Factors
  2. Lamotrigine & Cardiac Risk: FDA Warning

Topiramate

  1. Topiramate and Cognitive-Related Dysfunction

Hydroxyzine

  1. Hydroxyzine and QTc Prolongation

Serious Rashes Associated with Mood Stabilizers

  1. Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis
  2. Rash Evaluation & Diagnosis
  3. DRESS Syndrome

ADVERSE EVENTS: SEXUAL DYSFUNCTION WITH PSYCHOTROPICS

What Questions to Ask?

Antidepressants & Sexual Dysfunction

  1. Comparing Antidepressants
  2. Risk with SSRIs
  3. Management of Sexual Dysfunction with Antidepressants
  4. Ginkgo Biloba for Antidepressants Induced Sexual Dysfunction

Antipsychotics & Sexual Dysfunction

  1. Which One is Preferred?
  2. Management of Sexual Dysfunction with Antipsychotics

Psycho-Ophthalmology: Psychotropics Ocular Adverse Events

Angle Closure Glaucoma

  1. Symptoms, Risk-Factors & Prevention
  2. Angle Closure Glaucoma & ANTIDEPRESSANTS
  3. Angle Closure Glaucoma & OTHER PSYCHOTROPICS
  4. ECT in the setting of Glaucoma

Uveal Tract Disorders

  1. Tricyclic Antidepressants
  2. Topiramate
  3. SSRIs
  4. Antipsychotics

Impaired Eye Movements (Nystagmus)

Other Ocular Adverse-Events

  1. Epithelial Keratopathy
  2. Allergic conjunctivitis
  3. Alice in Wonderland syndrome (Dysmetropsia)
  4. Exophthalmos and Papilledema
  5. Palinopsia

Non-Psychiatric Medications: Neuropsychiatric Adverse Events

  1. Steroids
  2. Interferon
  3. Levetiracetam
  4. Isotretinoin
  5. Fluoroquinolones
  6. Mefloquine
  7. Montelukast (Singulair)

Psychotropics Drug-Drug Interactions

Antipsychotics

  1. Medications affecting Clozapine Levels
  2. Clozapine, Neutropenia & Medication Interactions
  3. Medications affecting Aripiprazole Levels

Antidepressants

  1. Antidepressants & Caffeine
  2. Antidepressants & Cardiac Medications
  3. Antidepressants & Tramadol
  4. MAOI Drug Interactions
  5. MAOI Diet

Mood Stabilizer

  1. Lamotrigine and Anticonvulsants
  2. Lamotrigine and Oral Contraceptive Pills
  3. Lamotrigine and Clozapine
  4. Lithium Drug Interactions

Hydroxychloroquine

Warfarin

  1. Warfarin & Antipsychotics
  2. Warfarin & Antidepressants

HIV/AIDS Medications

  1. Mood Stabilizers & HIV/AIDS Medications
  2. Antidepressants & HIV/AIDS Medications
  3. Antipsychotics & HIV/AIDS Medications
  4. Methadone & Buprenorphine

Antibiotics

Oncology

Herbal Medications

Cannabis

Switching Psychotropics & Discontinuation

Switching Psychotropics

  1. Switching Oral Antipsychotics: Dose Equivalence
  2. Switching Benzodiazepines: Dose Equivalence
  3. Switching Antidepressants: Dose Equivalence

Psychotropic Discontinuation

  1. Chronic Benzodiazepine Discontinuation

Therapeutic Drug Monitoring (TDM): Psychotropic Levels

TDM: Mood Stabilizers

  1. Lithium
  2. Valproate
  3. Lamotrigine

TDM: Antipsychotics

  1. Aripiprazole
  2. Risperidone
  3. Olanzapine
  4. Clozapine
  5. Quetiapine
  6. Ziprasidone
  7. Other Atypical Antipsychotics
  8. Recommendations for Therapeutic Drug Monitoring

TDM: Antidepressants

  1. SSRIs
  2. SNRIs
  3. NDRI
  4. NaSSAs
  5. Serotonin Modulators
  6. NRI
  7. TCAs

Long Acting Injectables

  1. Haloperidol Decanoate
  2. Fluphenazine Decanoate
  3. Risperidone Consta
  4. PERSERIS™ (Risperidone Once-Monthly Injectable)
  5. Paliperidone- Invega Sustenna
  6. Paliperidone- Invega Trinza
  7. Abilify Maintena

MAJOR DEPRESSION DISORDER (MDD)

MDD Augmentation Strategies

  1. Atypical Antipsychotics
  2. Lithium
  3. Thyroid Hormones
  4. L-Methylfolate
  5. Lamotrigine
  6. Stimulants
  7. Buspirone
  8. Pramipexole
  9. S-Adenosyl Methionine (SAMe)
  10. Low Dose Naltrexone

Evidence Based Treatment Guidelines

  1. Update On Nonpsychotic Unipolar Depression Management
  2. Comparing Guidelines for MDD Treatment: Pharmacotherapy vs Psychotherapy
  3. Florida Best Practice Guidelines (2017- 2018)
  4. Florida Best Practice Guidelines (2017- 2018): MDD with Mixed Features
  5. Florida Best Practice Guidelines (2017- 2018): MDD with Psychosis

MDD PsychoPharamcology

  1. Ketamine Role in Psychiatry & Risk of Psychosis
  2. Trazodone Once-A-Day for MDD
  3. Transdermal Selegiline for MDD
  4. Auveity: new Antidepressant for MDD
  5. Gepirone (Exxua): New Antidepressant FDA Approved for MDD
  6. Rejoyn: FDA Cleared First Prescription Digital Therapeutic for MDD
  7. How Long to Continue Antidepressants for MDD Treatment?
  8. Medications vs Psychotherapy for MDD: Guidelines Comparison.
  9. Antidepressants Discontinuation Syndrome Vs Depression Relapse
  10. Psychotropic Medication of choice to Improve Cognition in MDD
  11. Sleep-Wake Cycle & Antidepressants
  12. Antidepressants of Choice in Adolescents & Monitoring

Comparing Antidepressants

  1. SSRIs vs SSRIs (Part-1)
  2. SSRIs vs SSRIs (Part-2)
  3. Serotonin Modulators: Trazodone vs Nefazodone
  4. Serotonin Modulators: Vortioxetine vs Vilazodone
  5. Comparing Long ActingAntidepressants Formulations
  6. Comparing Antidepressants: Which one is better?

Post Stroke Depression

  1. Pathophysiology & Risk Factors
  2. Treatment of Post Stroke Depression
  3. Prevention of Post Stroke Depression

Grief

  1. Grief versus Major Depressive Episode
  2. Persistent Complex Bereavement Disorder Versus Prolonged Grief Disorder
  3. What Questions to Ask? Grief Assessment Questionnaire.

Back to Basics

  1. Serotonin: Basics and Beyond
  2. Mechanism of Action: Antidepressants (Part-1)
  3. Mechanism of Action: Antidepressants (Part-2)
  4. Suicide Risk Assessment

Bipolar and Related Disorder

Evidence Based Treatment Guidelines

  1. CANMAT and ISBD (2018 Guidelines): Acute Management of Bipolar Mania
  2. CANMAT and ISBD (2018 Guidelines): Acute Management of Bipolar I Depression
  3. CANMAT and ISBD (2018 Guidelines): Maintenance therapy for Bipolar I Disorder
  4. CANMAT and ISBD (2018 Guidelines): Management of Bipolar II Disorder
  5. Florida Best Practice Guidelines (2017- 2018): Bipolar Depression
  6. Florida Best Practice Guidelines (2017- 2018): Bipolar Mania
  7. Florida Best Practice Guidelines (2017- 2018): Bipolar Maintenance
  8. British Association for Psychopharmacology (2016)

Bipolar Depression

  1. Managing Bipolar Depression: Treatment Update 2023
  2. Is Watchful Waiting Appropriate for Bipolar Depression?
  3. Antidepressants in Bipolar Depression: When to Use & When to Avoid?
  4. How Long to Continue Adjunct Antidepressants in Bipolar Depression?
  5. Is Lamotrigine >200 mg Effective for Bipolar Depression?
  6. Is Quetiapine 600 mg More Efficacious than 300 mg for Bipolar Depression?
  7. Which Subgroup of Bipolar Disorder Patients Respond Well to Lithium?

Bipolar Mixed Features

  1. How to Diagnose Bipolar Mixed Feature Specifier?
  2. Why is Diagnosing Mixed State Important?
  3. Assessment Scales for Mixed State Evaluation
  4. Management of Bipolar Mixed Features

Bipolar Disorder PsychoPharamcology

  1. Anti-Manic Agent of Choice?
  2. Pramipexole for Bipolar Depression
  3. Comparing Mood Stabilizers
  4. Comparing FDA Approved Medications: Bipolar Depressed
  5. How Long to Continue Antipsychotics After Mania Remission?
  6. Is Quetiapine 600 mg Superior to 300 mg for Bipolar I and II Depression?
  7. Restarting Lamotrigine after abrupt Discontinuation
  8. Cariprazine (Vraylar) for Depressive Episodes in Bipolar I Disorder.
  9. Iloperidone: FDA Approval for Bipolar 1 Disorder (Acute Manic or Mixed Episodes)

Bipolar Disorder and Comorbid ADHD

Bipolar 2 Disorder

OBSESSIVE COMPULSIVE AND RELATED DISORDERS

OCD Psychopharmacology Algorithm

Obsessions versus Delusions?

OCD: When to Discontinue Treatment?

OCD Augmentation with N-acetyl cysteine (NAC)

Postpartum Onset OCD

Antipsychotics of Choice in Schizo-Obsessive Disorder

Excoriation (Skin-Picking) Disorder

  1. Excoriation Disorder Non-Pharmacological Management
  2. Excoriation Disorder Pharmacological Management

Anxiety and Related Disorders

Generalized Anxiety Disorder: Treatment Algorithm

  1. GAD: Initial Serotonergic Medication of Choice?
  2. Treatment Resistant GAD: Augmentation Strategies
  3. Treatment Resistant GAD: Switch Options
  4. MM120 Receives FDA Breakthrough Therapy Designation for GAD

Nutritional Psychiatry: Anxiety Disorders

  1. L-Theanine for Anxiety Management
  2. Silexan for Anxiety Management

TRAUMA AND STRESS-RELATED DISORDERS : POST TRAUMATIC STRESS DISORDER

Introduction to PTSD

  1. Welcome Message (by Dr. Singh)
  2. PTSD vs Complex PTSD: How to Diagnose?
  3. Introduction to PTSD & Psychopharmacology Algorithm Project (Dr. Osser)
  4. Managing PTSD with Comorbidities

PTSD, Insomnia and Nightmares

  1. Sleep Problems with PTSD: Assessment & Management.
  2. Prazosin: for PTSD nightmares or disturbed awakenings
  3. Prazosin Dosing & Titration: for Men & Women
  4. Terazosin: for PTSD nightmares
  5. Doxazosin: Medication option if Prazosin/Terazosin Fails
  6. Managing Poor Onset Insomnia with NO Nightmares or Hyperarousal symptoms

Antidepressants, Psychosis & Treatment-Resistant PTSD

  1. Role of SSRIs for PTSD Management
  2. PTSD related Psychosis Management
  3. SNRI, Mirtazapine & Bupropion for PTSD Management
  4. Treatment-Resistant PTSD Management
  5. Cyproheptadine for PTSD Nightmares
  6. Nabilone: Synthetic Cannabinoid for PTSD Nightmares

PTSD Scales

  1. International Trauma Questionnaire (ITQ) for PTSD Assessment

TRAUMATIC BRAIN INJURY

Depression after Traumatic Brain Injury

Aggression after Traumatic Brain Injury

Bipolar Disorder after Traumatic Brain Injury

Cognitive Impairment after Traumatic Brain Injury

Insomnia after Traumatic Brain Injury

TBI Severity Classification

Neuroanatomical Correlates of TBI Symptoms

SCHIZOPHRENIA & OTHER PSYCHOTIC DISORDERS

Antipsychotics: Psychopharmacology

  1. Clozapine Resistant Schizophrenia: Treatment Options
  2. Comparing Antipsychotics & Pneumonia Risk
  3. Clozapine Missed Dose Management
  4. Aripiprazole vs Brexpiprazole
  5. Asenapine Formulations: Topical vs Sublingual
  6. Comparing Antipsychotics for Schizophrenia Treatment
  7. Xanomeline-Trospium Chloride (KarXT) for Schizophrenia

Psychological Approaches for Psychosis

Schizophrenia Staging with PANSS

Atypical Psychosis

  1. When is First Episode Psychosis Atypical?
  2. Which Investigations are Needed for Late-Onset Psychosis?
  3. Performing Rapid Neurological Exam for Atypical Psychosis.

WOMEN'S MENTAL HEALTH: PREGNANCY, POST-PARTUM & PERI-MENOPAUSE

Antipsychotics

  1. Antipsychotics During Pregnancy & Postpartum
  2. Antipsychotics: Rates of Placental Passage
  3. Antipsychotics of Choice during Lactation

Antidepressants

  1. Zuranolone FDA Approved for Postpartum Depression
  2. Antidepressants During Pregnancy & Postpartum
  3. Antidepressants of Choice during Lactation

Mood Stabilizers

  1. Preconception Planning: Preparing for Pregnancy
  2. Continue or Discontinue Medication during Pregnancy & Postpartum?
  3. Lithium: During Pregnancy & Postpartum
  4. Lithium: use during Lactation
  5. Valproate: During Pregnancy & Postpartum
  6. Lamotrigine: During Pregnancy & Postpartum
  7. Other Mood Stabilizers: During Pregnancy & Postpartum
  8. Other Mood Stabilizers: use during Lactation

Benzodiazepines

ADHD Medication

Postpartum Onset OCD

Postpartum Psychosis

Perimenopausal Depression

PMDD

ADDICTION PSYCHIATRY: SUBSTANCE USE DISORDERS

Alcohol Use Disorder

  1. Medications for Alcohol Use Disorder Treatment
  2. Alcohol Withdrawal: Medications Comparison
  3. Alcohol withdrawal Protocol for Inpatient Setting
  4. Gabapentin Protocol for Alcohol Withdrawal Management

Opioid Use Disorder

  1. Medications for Opioid Use Disorder Treatment
  2. Naltrexone XR for Opioid Use Disorder
  3. Methadone Dosing: for Opioid Use Disorder & Pain Management
  4. Methadone: Drug Interactions
  5. Buprenorphine: Dosing & Drug Interactions
  6. Brixadi: FDA Approved First Long-Acting Buprenorphine for Opioid Use Disorder  

Cannabis Use Disorder

  1. NAC for Cannabis Use Disorder

Nicotine Use Disorder

  1. Varenicline for Nicotine Use Disorder
  2. Buproprion SR for Nicotine Use Disorder
  3. Nortriptyline for Nicotine Use Disorder

False Positive Urine Drug Screens

Designer Drugs

GERIATRIC PSYCHIATRY: NEUROCOGNITIVE DISORDERS

Behavioral Symptoms Management in Dementia

  1. Behavioral & Psychological Symptoms in Dementia: Treatment Update
  2. Behavior Types & Clinical Relevance: Behavioral Symptoms in Dementia
  3. Evaluation and Differential Diagnosis: Behavioral Symptoms in Dementia
  4. Non-Pharmacologic Management: Behavioral Symptoms in Dementia
  5. Depression with Dementia: Treatment Options
  6. Antipsychotics use for Psychosis/Agitation Management in Dementia
  7. Treatment Options of Sexually Inappropriate Behavior in Dementia

Neurocognitive Disorders

  1. Evaluating Neurocognitive Domains in Dementia
  2. Alzheimer’s Disease: Comparing FDA Approved Medications
  3. Use of Benzodiazepines in Elderly?
  4. Modifiable Predictors of Conversion of Mild Cognitive Impairment to Dementia
  5. Identifying Dementia Patient at Risk of Unsafe Driving
  6. How to Screen for Delirium Superimposed on Dementia?

Bipolar Disorder in Elderly

Parkinson’s disease

CHILD AND ADOLESCENT PSYCHIATRY

Autism Spectrum Disorder (ASD)

  1. ASD: Comparing Medications in ASD (Net Benefit Score)
  2. ASD: Aggression & Irritability
  3. ASD: Anxiety
  4. ASD: Depression
  5. ASD: Attention, Hyperactivity & Cognition
  6. ASD: Sensory Sensitivity
  7. ASD: Tics/Abnormal Movements
  8. ASD: Insomnia
  9. ASD: Self Injury

Bipolar Disorder

  1. Antipsychotics vs Mood Stabilizers: for Acute Mania

ADHD

  1. Comparing Methylphenidate Long-Acting Formulations
  2. Guanfacine XR for ADHD

PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)

  1. PANS: Diagnostic Evaluation
  2. PANS: Management

FEEDING & EATING DISORDERS

Binge Eating Disorder (BED)

  1. How to Diagnose BED?
  2. BED: Medications Treatment Options

Anorexia Nervosa

  1. Anorexia Nervosa: How to Diagnose, Evaluate & Treat

INSOMNIA & RELATED DISORDERS

Chronic Insomnia

IMPULSE CONTROL & RELATED DISORDERS

Naltrexone for Impulse Control & Self-Injurious Behaviors 

Parkinson’s Disease & Impulse Control Disorders

Managing/Ruling out Co-Morbid Medical Conditions

Metformin in Psychiatry

Hypogonadism/Low Testosterone

  1. Hypogonadism/Low Testosterone: Diagnosis & Scales
  2. Hypogonadism/Low Testosterone: Treatment

Restless Legs Syndrome

Anti-NMDA Receptor Encephalitis

  1. Anti-NMDA Receptor Encephalitis: Clinical Presentation
  2. Anti-NMDA Receptor Encephalitis: Diagnosis & Treatment
  3. Anti-NMDA Receptor Encephalitis: Discussion with Neurologist Dr. Seyed Mirsattari 

Pseudobulbar Affect

Delirium

  1. Delirium Treatment: Role of Antipsychotics
  2. Delirium Rating Scale-Revised-98 (DRS-R-98)
  3. Delirium Treatment: Haloperidol
  4. Olanzapine versus Haloperidol for Delirium Management
  5. Quetiapine versus Haloperidol for Delirium Management
  6. Risperidone for Delirium in Elderly
  7. Prophylactic Antipsychotics: Prevention Strategy?
  8. Delirium Treatment: Role of Depakote

Catatonia

  1. Catatonic Disorder Due to Another Medical Condition: 293.89 (F06.1)
  2. Catatonia: Treatment Recommendations

Subclinical Hypothyroidism

  1. Risk Factors for High and Low TSH Level
  2. USPSTF Screening Recommendation for thyroid dysfunction
  3. Will you initiate thyroid replacement therapy?
  4. Medications causing Hypothyroidism

Iron Deficiency Anemia

  1. Iron Deficiency Anemia: Diagnosis Algorithm
  2. Iron Deficiency Anemia: Evaluation Algorithm

Obstructive Sleep Apnea and CPAP

Lyme’s Disease

Statin Treatment

Burning Mouth Syndrome

COVID-19 & Psychiatry

  1. Pulmonary: COVID-19 & Psychiatry
  2. Cardiac: COVID-19 & Psychiatry
  3. Hematologic: COVID-19 & Psychiatry
  4. Drug-Drug Interactions: COVID-19 Medications & Psychotropics
  5. Psychotropics Monitoring During COVID-19

Genetic Testing in Psychiatry

Genetic Testing in Psychiatry

  1. MTHFR & L-MethylFolate
  2. SLC6A4

Integrative and Complementary Psychiatry

  1. St. John’s Wort for Depression
  2. Omega 3 Fatty Acids for Depression
  3. L-Theanine for Anxiety
  4. Silexan for Anxiety
  5. NAC for OCD
  6. Ginkgo Biloba for Antidepressants Induced Sexual Dysfunction

ACADEMY Live SESSIONS

Academy Live Sessions

  1. Facebook Live 001 (March 09, 2024)
  2. Facebook Live 002 (April 06, 2024)
  3. Facebook Live 003 (May 18, 2024)

To All Academy Members:
Join Facebook Group to Stay Updated

We created this closed Facebook group for the following important reasons:
 
(1) Discuss your Questions & Clinical Cases: I review each member’s medical professional status before approving the request so that we all can discuss our questions among medical professionals only.
 
(2) Ask for Referrals & Grow your Professional Network: by connecting with other medical professionals in our closed Psychiatry Education Forum community.
 
(3) Stay Updated: get immediate updates when new topics are posted in:

(4) Facebook Live: We do monthly Facebook Live in this closed group to discuss recent advances in the field of psychiatry.

JOIN FACEBOOK GROUP (FOR ACADEMY MEMBERS ONLY)

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .